Dr. Ashish Kumar Gastroenterologist in Delhi

Dr. Ashish Kumar

Gastroenterologist, Delhi

MBBS, MD, DM

  • 18 Years Experience
  • 1 Hospital

About

  • Dr. Ashish Kumar is an Associate Professor and Consultant in the Department of Gastroenterology & Hepatology at Sir Ganga Ram Hospital
  • Dr. Ashish Kumar is currently working on developing a national consensus on treatment of liver cancer under aegis of INASL
  • Dr. Ashish Kumar is associated with Ganga Ram Institute for Postgraduate Medical Education & Research (GRIPMER), New Delhi
  • Dr. Ashish Kumar worked as an Associate Professor of Hepatology at the Institute of Liver & Biliary Sciences (ILBS), New Delhi

Specialities

  • Gastroenterology

  • Hepatology

  • Hepatobiliary Surgery

Expertise

  • Liver diseases
  • Cirrhosis
  • Portal Hypertension
  • Liver failure
  • Stem cell therapy Hepatitis B
  • Hepatitis C
  • Hepatitis E
  • Liver diseases in pregnancy
  • Acute-on-chronic liver failure

Education

  • MBBS from GSVM Medical College, Kanpur, 1994
  • MD (Gen Med) from King George’s Medical College, Lucknow, 1999
  • DM (Gastroenterology) from Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 2004
  • Mentorship of Prof Shiv Kumar Sarin he did Senior Research Associateship in Hepatology

Practice Information

Sir Ganga Ram Hospital (SGRH), Delhi

Sir Ganga Ram Hospital (SGRH), Delhi

Rajinder Nagar, Delhi, Delhi - 110060

MON, TUE, WED, THU, FRI, SAT

08:00 AM - 10:00 PM

Achievements & Contributions

  • Kumar A, Sarin SK. Hepatitis B Virus Related Acute-on-Chronic Liver Failure. In Mahtab MA, Akbar SMF, Rahman S (editors): Comprehensive Textbook of Hepatitis B. Jaypee Brothers Medical Publishers, New Delhi 2011:120-132
  • Kumar A, Sarin SK. Hepatic venous pressure gradient: Methodology and technique. In Proceedings of APASL Single Topic Conference on Liver Fibrosis with or without Hepatitis B or C, Cairo, Egypt 2008; Jan 30-Feb 01
  • Arora A, Kumar A. Cirrhosis of liver. In Mahtab MA, Akbar SMF, Hasan M (editors): Hepato-Gastroenterology – A Comprehensive Text Book. Jaypee Brothers Medical Publishers, New Delhi 2012
  • Sarin SK, Kumar A, Chawla YK. Extra hepatic portal vein obstruction (EHPVO). In de Franchis R (editor): Portal Hypertension V: Proceedings of the Fifth Baveno International Consensus Workshop (5th ed.). Wiley-Blackwell, Oxford 2010:151-164
  • Sharma P, Kumar A, Sarin SK. Acute on chronic liver failure: Management. In Proceedings of APASL Single Topic Conference on Innovative of CHB Management, Pattaya, Thailand 2007; Nov 22-24
  • Sarin SK, Kumar A. Update on portal hypertension: 2007. In APASL 2007 Postgraduate Course B: Recent Progress in Basic Hepatology, Kyoto, Japan 2007; Mar 27:43-56
  • Sarin SK, Kumar A. Endoscopic Banding for Primary Prophylaxis: Based on Evidence? In Syllabus for the 2007 ASGE Annual Postgraduate Course, Washington DC, USA 2007
  • Fifty publications in international journals, including Gastroenterology, Annals of Internal Medicine
  • Dr. Ashish Kumar was one of the faculty members of the recent Baveno conference on portal hypertension, and also of many consensus conferences by APASL on portal hypertension
  • Presented the work "Beta-blocker is as effective as endoscopic variceal ligation (EVL) in secondary prophylaxis of variceal bleeding in patients with extra-hepatic portal vein obstruction” as poster in the “EASL Monothematic Conference: Portal Hypertension: Advances in Knowledge, Evaluation and Management” at Budapest, Hungary, on January 22-24, 2009
  • Nominated as “Honorary Gastroenterologist” to the Supreme Court of India in December 2008
  • Presented  a paper at the “Plenary Session of the APDW 2008”, New Delhi, India on 14-Sep-2008, entitled “Endoscopic variceal ligation plus propranolol and isosorbide mononitrate versus endoscopic variceal ligation alone for secondary prophylaxis of variceal bleeding: A large prospective randomized controlled trial”
  • Delivered a talk on “ACLF Consensus Report” on 09-Mar-2008 in the “Annual Conference of Indian National Association for Study of the Liver (INASL)”, New Delhi (07-Mar-2008 to 09-Mar-2008)
  • Delivered a talk on “HVPG Technique” and participated in the “APASL Working Party Consensus Development Meeting on Liver Fibrosis” on 29-Jan-2008 at the “3rd APASL Single Topic Conference” in Cairo, Egypt on 29-Jan-2008 to 01-Feb-2008
  • Organized the “APASL Working Party on Acute on Chronic Liver Failure Live-Data Share and Consensus Development Meeting”, New Delhi, India on January 22-23, 2008
  • Organized the “Round Table Conference on Definition, Epidemiology, and Diagnostic Criteria of Acute on Chronic Liver Failure (ACLF)”, New Delhi on December 16, 2007 at New Delhi
  • Delivered a talk on “HVPG: How I do it” on 17-Nov-2007, in the “ISGCON 2007” at Bangalore, India
  • Delivered a talk on “Chronic HBV: High viral load and normal transaminase: Should we treat or not?” at “Mid-term ISG Meet” on 01-Sep-2007 at SGPGIMS, Lucknow, India
  • Presented poster “Natural history of asymptomatic and symptomatic portal biliopathy in patients with extra-hepatic portal vein obstruction (EHPVO)” at the “Digestive Disease Week 2007” at Washington DC, USA on May 19-24, 2007
  • Organized the “APASL Working Party on Portal Hypertension Consensus Development Meeting on Non-Cirrhotic Portal Fibrosis and Primary Prophylaxis of Variceal Bleeding”, New Delhi, India on January 12-13, 2007
  • Received the best paper award at the “Plenary Session of ISG-INASL 2006”, Mumbai, India, for the paper entitled “Endoscopic variceal ligation (EVL) plus propranolol (P) and isosorbide mononitrate (ISMN) versus endoscopic variceal ligation alone in secondary prophylaxis of variceal bleeding: A prospective randomized controlled trial.”
  • Did observership for 3 weeks at the Department of Gastroenterology, UCSF Medical Center, University of California, San Francisco, California, USA (16-Nov-2005 to 07-Dec-2005)
  • Attended the “AASLD 2005 Liver Meeting” at San Francisco, USA on 11-Nov-2005 to 15-Nov-2005
  • Delivered a lecture “Etiology of Non-Cirrhotic Portal Hypertension” at the “19th Annual Conference of the Indian National Association for the Study of Liver (INASL) in association with International Liver Transplant Society (ILTS)” held on 25-27 March, 2011 at PGIMER, Chandigarh
  • Delivered three lectures (a. “The effect of beta-blockers in cirrhosis beyond the reduction of portal pressure”; b. “Acute variceal Bleeding – APASL guidelines”; c. “Scoring System in ACLF: Anything new”) at the “21st Conference of the Asian Pacific Association for the Study of the Liver” held on 17-20 February 2011 at Bangkok, Thailand
  • On 11 February, 2011, nominated to be the Editorial Board Member of the Indian Journal of Gastroenterology, the official publication of the Indian Society of Gastroenterology (ISG)
  • Invited to be a panelist at the Single Theme INASL meeting on “Acute Liver Failure” held at Medanta – The Medicity, Delhi NCR, on 18th and 19th December 2010
  • Delivered a lecture “How to Use Prognostic Models in the Management of Alcoholic Hepatitis” at the “INASL Midterm Conference” held in Hyderabad on November 24th 2010, in association with the 51st Annual Conference of ISG
  • On 30 November, 2010, nominated as the Editorial Board Member of the Journal of Clinical and Experimental Hepatology (JCEH). JCEH is the official, peer-reviewed publication of the INASL published quarterly by Elsevier
  • Delivered a lecture “SBP: Diagnosis, treatment and prevention” at the “Current Perspectives in Liver Disease (CPLD) Conference on Management of End-Stage Liver Disease”, held on October 15 – 16, 2010, at All India Institute of Medical Sciences (AIIMS), New Delhi
  • Delivered a lecture “ACLF: Do we need another terminology?” at the “Asian Pacific Digestive Week (APDW) 2010”, held on September 19 – 22, 2010, at Kuala Lumpur, Malaysia
  • Invited to be panelist at the “Baveno V 20th Anniversary Workshop and Postgraduate Course: current consensus and future directions in the diagnosis and treatment of portal hypertension”, held in Stresa, Lake Maggiore, Italy, from May 21 to May 22, 2010
  • Delivered a distinguished lecture “Pathology of Cirrhosis: Liver Dysfunction and Portal Hypertension” in the Concurrent Session of “Cirrhosis And Portal Hypertension” at the “20th Conference of the Asian Pacific Association for the Study of the Liver (APASL)” held from 25 - 28 March, 2010 in Beijing, China
  • Delivered a lecture “How I manage ACLF” at the “18th Annual INASL Conference” on March 12, 2010 at Bhubaneswar, India
  • Delivered a lecture “Liver & kidney interactions in health and disease” at the “INASL Mid-term Conference in Association with the 50th Annual ISG Conference”, held on 9 - 13 December, 2009 at Kolkata, India
  • Delivered a lecture “HVPG – Is it the key in the management of liver disorders?” at the “Current Perspectives in Liver Diseases (CPLD) Conference”, held on 5 - 6 December, 2009 at Chandigarh, India
  • Presented the works "Cirrhotic patients with large esophageal varices and higher age have poor hemodynamic response to terlipressin” and “Natural history of asymptomatic and symptomatic portal biliopathy in patients with extra-hepatic portal vein obstruction (EHPVO)” as posters at the “UEGW/WCOG GASTRO 2009 Conference” on November 21 - 25, 2009 at London, United Kingdom
  • Invited to deliver a lecture “Does the degree of liver fibrosis correlate with portal pressure?” at a symposium “Hepatic fibrosis: Non-invasive diagnosis and management” held on 8th November 2009, at Institute of Liver and Biliary Sciences, New Delhi, India
  • Delivered a lecture "HBV in Pregnancy" at the “6th Symposium: Liver Diseases at the Crossroads of Civilization: East meets West”, held at Alexandria, Egypt, from September 24th through September 25th, 2009
  • Delivered a distinguished lecture "Portal Pressure: Measurement and correlation with Complications" at the “Postgraduate Course” during the “19th Conference of the Asian Pacific Association for the Study of the Liver (APASL)” held in Hong Kong on 13 – 16 February 2009
  • Organized the “APASL Consensus Meeting on Acute Variceal Bleeding” at India Habitat Centre, New Delhi, India on January 31 – February 1, 2009
  • Organized a “Workshop on Balloon-occluded Retrograde Transvenous Obliteration (BRTO)” at G B Pant Hospital, New Delhi on January 30, 2009
  • Delivered a lecture “Nonalcoholic fatty liver disease in India - is it different?” at the FORTISCON - HEPATOLOGY REVISITED organized by the Department of Gastroenterology, Fortis Hospital, Shalimar Bagh, New Delhi on 28 April 2013
  • Delivered a lecture “Rational Investigations for Liver Diseases” at a CME "New Horizons in Hepatology" organized by the LIVER HEALTH FOUNDATION in Varanasi on the 13th of April, 2013
  • Presented the “INASL consensus on HCC (The Puri Recommendations)” at the 21st Annual INASL Conference held at Hyderabad on  22-24 March, 2013
  • Delivered a lecture on “HCV and HCC” at the meeting of INASL HCV Task-Force at Gurgaon on 28-Feb-2013
  • Organized the Round Table Discussion of the INASL Task-Force on HCC for developing the INASL Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India, at Puri, Odisha on 9-10 February, 2013
  • Appointed as Associate Professor of the GRIPMER (Ganga Ram Institute for Postgraduate Medical Education & Research), Sir Ganga Ram Hospital on 5th January, 2013
  • Appointed on 26th November, 2012, as the Editorial Board Member of the Vigour Zoom Health Magazine, a health magazine targeting the general practitioners of India
  • Chaired a session on “Cryptogenic Cirrhosis & HCC in NAFLD” in the INASL single theme conference “NASH Conclave: The Indian Scenario” on 3-4 November, 2012 at New Delhi
  • Delivered a lecture “Assessment of Hepatic fibrosis: Needle vs Balloon vs Probe” at the “Current Perspectives in Liver Diseases (CPLD) - 2012 and Single Theme Conference on Hepatocellular Carcinoma” held on October 13 - 14, 2012 at Chandigarh, India
  • Delivered a lecture “Pathogenesis of ACLF” at the “Asian Pacific Association for the Study of the Liver (APASL) 3rd Single Topic Conference on Hepatitis B Virus” held on October 6 – 7, 2012 in Dhaka, Bangladesh
  • Chaired the session of “Treatment of Portal Hypertension and Ascites” at the Indo-Spanish Symposium on Liver Diseases on “Recent advances in portal hypertension” on September 30, 2012 at the Institute of Liver & Biliary Sciences (ILBS), New Delhi, India
  • On September 23, 2012 nominated to be an Editorial Board Member of the Journal of Gastroenterology and Hepatology Research (JGHR), a monthly, open accessed, peer reviewed journal, published from Hong Kong, China
  • Organizing Vice Chairperson of the Mid-Term INASL Meeting on “Medical Emergencies in Hepato-Biliary Diseases” held on September 15-16, 2012 at the India Habitat Centre, New Delhi, India
  • Nominated on 18th July, 2012 as the Editorial Board member of the Journal of Clinical and Translational Hepatology
  • Delivered a lecture “HBV in Pregnancy” at “Round Table Discussion on Management of Hepatitis B” organized by the Bristol-Myers Squibb on 30th June, 2012
  • Selected to participate in the Inter-Society Activity Course (ISAC) on “Interventions in Liver Disease” organized by The European Association for the Study of the Liver (EASL) in cooperation with European Society of Gastrointestinal Endoscopy (ESGE) and the European Society for Gastrointestinal and abdominal Radiology (ESGAR) on June 7 – 8, 2012 in Paris, France
  • Gave live demonstration of “Hepatic Venous Pressure Gradient (HVPG)” measurement at the workshop “Advances in Diagnostic and Therapeutic Endoscopy” organized by the Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital, on 18th and 19th May, 2012
  • Presented the research work entitled “Adrenal insufficiency predicts early mortality in patients with cirrhosis” at the “Hepatology Live 2012 Conference” held on 11th  to 13th May 2012 at Vienna, Austria. The research work was shortlisted as one of the 16 finalist from over 300 entries sent from all over the world
  • Invited to be the Chairperson and Moderator at the “13th Annual Meeting of Society of Gastrointestinal Endoscopy of India”, held on 27th-29th April, 2012 at Kolkata, India
  • Invited to chair a session at the “2nd GI & Liver Scientific Meeting” at Yangon, Myanmar on January 28-29, 2012
  • Invited to chair a session at the “Symposium on Contemporary and Emerging Trends in Hepatology – Clinical Case Scenarios” for the APASL School of Hepatology, on 15th Jan, 2012 at the Institute of Liver & Biliary Sciences, New Delhi, India
  • Delivered lecture “Management of Hepatitis B: Beyond Udiliv and Liv 52” at the “54th Annual conference of the Delhi Medical Association”, held on 8th January, 2012 at the Hotel Taj at New Delhi
  • Delivered lecture “Management of Hepatitis B: Beyond Udiliv and Liv 52” and participated at multiple CMEs on “Recent Advances in Gastroenterology”, organized by the Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital, held at various IMAs during December 2011 and January 2012
  • Delivered lecture “Systemic problems in Cirrhosis” on 19th November, 2011 at the “ISGCON 2011”, held at Coimbatore. Also participated in the debate “Should INASL formulate separate HBV guidelines for Indians?” on 21st November, 2011 at the “INASL Meeting of the ISGCON 2011”
  • Delivered a lecture “Liver Function Tests: Indications & Significance” at the “CME for Physicians” organized by Sir Ganga Ram Hospital at the India Habitat Centre, on November 6, 2011
  • Organizing secretary of the “Mid-Term INASL Meeting - Recent Advances in Hepatology for Clinicians” held on 8th & 9th October 2011 at the India Habitat Centre, New Delhi, India. Also delivered a lecture there “Role of HVPG in management of liver diseases”
  • Participated in the “Systematic review and Meta-analysis Workshop” at Lucknow, India on September 16-18, 2011
  • Delivered a lecture “Role of Non-specific Hepatoprotective Agents in Chronic Liver Diseases” at a conference “Hepatology made easy for Physicians” on the 3rd of July 2011 at Medanta-The Medicity Hospital, Sector 38 Gurgaon
  • Delivered a lecture “Management of Gastric Varices and Portal Hypertensive Gastropathy” at the “17th Annual Meeting of the Korean Association for the Study of the Liver (KASL)” held in Seoul, Korea on June 9-11, 2011
  • Paper Selected for Plenary Presentation at the APDW 2008, Delhi
  • Young Investigator Award at the APASL 2008, Seoul, Korea
  • Best Paper Award at the plenary session of ISG-INASL 2007, Mumbai
  • Hepatology 360 Award Finalist at the Hepatology Live 2012 Conference held at Vienna
  • Kumar A, Jha SK, Sharma P, Dubey S, Tyagi P, Sharma BC, Sarin SK. Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence. Gastroenterology 2009;137:892-901
  • Kumar A, Mishra SR, Sharma P, Sharma BC, Sarin SK. Clinical, Laboratory, and Hemodynamic Parameters in Portal Hypertensive Gastropathy: A Study of 254 Cirrhotics. J Clin Gastroenterol. 2010;44:294-300
  • Kumar A, Das K, Sharma P, Mehta V, Sharma BC, Sarin SK. Hemodynamic Studies in Acute-on-Chronic Liver Failure. Dig Dis Sci 2009;54:869-78
  • Kumar A, Kumar SI, Pandey R, Naik S, Aggarwal R. Hepatitis B virus genotype A is more often associated with severe liver disease than genotype D in northern India. Indian J Gastroenterol 2005;24:19-22
  • Kumar A. Hepatitis B virus infection and pregnancy: a practical approach. Indian J Gastroenterol 2012;31:43-54
  • Kumar A, Sharma P, Sarin SK. Hepatic venous pressure gradient measurement: Time to learn! Indian J Gastroenterol 2008;27:74-80
  • Kumar A, TrehanPati N, Sarin SK. Use of stem cells for liver diseases: Current scenario. J Clin Exp Hepatol 2011;1:17-26
  • Kumar A, Choudhuri G, Aggarwal R. Piperacillin induced bone marrow suppression: a case report. BMC Clin Pharmacol 2003;3:2
  • Kumar A, Sharma P, Sarin SK. Adding variceal status to Child-Turcotte-Pugh score improves its performance in predicting early mortality in cirrhosis: the Child-Turcotte-Pugh-Kumar score. Eur J Gastroenterol Hepatol 2012;24:1348-9
  • Kumar A, Itha S. Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol 2005;100:2130-1
  • Sarin SK, Gupta N, Jha SK, Agrawal A, Mishra SR, Sharma BC, Kumar A. Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension. Gastroenterology 2010;139:1238-45
  • Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, Kumar A. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology 2011;53:774-80
  • Pande C, Sarin SK, Patra S, Bhutia K, Mishra SK, Pahuja S, Jain M, Srivastava S, Dar SB, Trivedi SS, Mukhopadhyay CK, Kumar A. Prevalence, risk factors and virological profile of chronic hepatitis B virus infection in pregnant women in India. J Med Virol 2011;83:962-7
  • Kotecha HL, Arora A, Chawlani R, Toshniwal J, Bansal N, Tyagi P, Sharma P, Kumar M, Kumar A. Low eosinophil count predicts in-hospital mortality in cirrhosis with systemic inflammatory response syndrome. Eur J Gastroenterol Hepatol 2013 Feb 13
  • Sarin SK, Mishra SR, Sharma P, Sharma BC, Kumar A. Early primary prophylaxis with beta-blockers does not prevent growth of small esophageal varices in cirrhosis: a randomized controlled trial. Hepatol Int 2012. Epub 2012 Mar 9
  • Sharma P, Kumar A. Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient. Saudi J Gastroenterol 2012;18:316-21
  • Arora A, Thawrani A, Kirnake V, Bansal N, Sachdeva M, Varma V, Nundy S, Ghuman SS, Buxi TB, Siraz F, Bhalla S, Kumar A. An unusual cause of lower GI bleeding in a young woman: metastatic gestational choriocarcinoma. Gastrointest Endosc 2012 Mar 13
  • Arora A, Tyagi P, Gupta A, Arora V, Sharma P, Kumar M, Goyal M, Kumar A. Pseudoaneurysm of the inferior phrenic artery presenting as an upper gastrointestinal bleed by directly rupturing into the stomach in a patient with chronic pancreatitis. Ann Vasc Surg 2012;26:860.e9-860.e11
  • Bansal N, Arora A, Kumaran V, Mehta N, Varma V, Sharma P, Tyagi P, Sachdeva M, Kumar A. Atypical Presentation of Cytomegalovirus Infection in a Liver Transplant Patient. J Clin Exp Hepatol 2011;1:207–209
  • Arora A, Tyagi P, Ghuman SS, Sharma P, Kotecha HL, Kumar A. Hepatocellular Carcinoma Presenting as Budd–Chiari Syndrome. J Clin Exp Hepatol 2012;2:91-2
  • Itha S, Kumar A. Endoscopy or surgery for malignant GI outlet obstruction? Gastrointest Endosc 2005;62:327
  • Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007;147:28-33
  • Gupta LB, Kumar A, Jaiswal AK, Yusuf J, Mehta V, Tyagi S, Tempe DK, Sharma BC, Sarin SK. Pentoxifylline therapy for hepatopulmonary syndrome: a pilot study. Arch Intern Med 2008;168:1820-3
  • Sharma P, Kumar A, Sharma BC, Sarin SK. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial. J Hepatol 2009;50:584-91
  • Sharma P, Kumar A, Shrama BC, Sarin SK. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am J Gastroenterol 2008;103:1689-97
  • Pande C, Kumar A, Sarin SK. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther 2009;29:1273-81
  • Sharma P, Kumar A, Sharma BC, Kumar Sarin S. Early identification of hemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'High-Risk' varices. Aliment Pharmacol Ther 2009; 30:48-60
  • Sharma P, Kumar A, Jha S, Mishra SR, Sharma BC, Sarin SK. Hemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients. Aliment Pharmacol Ther 2010;32:105-12
  • Kumar M, Kumar A, Hissar S, Jain P, Rastogi A, Kumar D, Sakhuja P, Sarin SK. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus. Liver Int 2008;28:690-8
  • Garg H, Kumar A, Garg V, Sharma P, Sharma BC, Sarin SK. Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis 2012;44:166-71
  • Pande C, Kumar A, Sarin SK. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial. Eur J Gastroenterol Hepatol 2012;24:831-9
  • Rastogi A, Kumar A, Sakhuja P, Bihari C, Gondal R, Hissar S, Garg H, Sarin SK. Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF). Virchows Arch 2011;459:121-7
  • Sharma P, Kumar A, Mehta V, Shrama BC, Sarin SK. Systemic and pulmonary hemodynamics in patients with non-cirrhotic portal fibrosis (NCPF) is similar to compensated cirrhosis. Hepatol Int 2007;1:275-80
  • Jha SK, Kumar A, Sharma BC, Sarin SK. Systemic and pulmonary hemodynamics in patients with extrahepatic portal vein obstruction is similar to compensated cirrhotic patients. Hepatol Int 2009;3:384-91
  • Gupta E, Kumar A, Choudhary A, Kumar M, Sarin SK. Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: A cross-sectional study. Indian J Med Microbiol 2012;30:150-4
  • Kumar SI, Kumar A, Srivastava S, Saraswat VA, Aggarwal R. Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study. Indian J Gastroenterol 2005;24:211-5
  • Sarin SK, Kumar A. Non cirrhotic portal hypertension. Clin Liver Dis 2006;10:627-51
  • Sarin SK, Kumar A, Angus PW, Baijal SS, Baik SK, Bayraktar Y, Chawla YK, Choudhuri G, Chung JW, de Franchis R, de Silva HJ, Garg H, Garg PK, Helmy A, Hou MC, Jafri W, Jia JD, Lau GK, Li CZ, Lui HF, Maruyama H, Pandey CM, Puri AS, Rerknimitr R, Sahni P, Saraya A, Sharma BC, Sharma P, Shiha G, Sollano JD, Wu J, Xu RY, Yachha SK, Zhang C, APASL Working Party on Portal Hypertension. Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations.
  • Itha S, Kumar A, Dhingra S, Choudhuri G. Dapsone induced cholangitis as a part of dapsone syndrome: a case report. BMC Gastroenterol 2003;3:21
  • Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, Sakhuja P, Sarin SK. Granulocyte-Colony Stimulating Factor Mobilizes CD34+ Cells and improves Survival of Patients with Acute-On-Chronic Liver Failure. Gastroenterology 2012;142:505-512.e1
  • Mishra SR, Chander Sharma B, Kumar A, Sarin SK. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut 2010;59:729-35
  • Mishra SR, Sharma BC, Kumar A, Sarin SK. Primary Prophylaxis of Gastric Variceal Bleeding Comparing Cyanoacrylate Injection and Beta-blockers: A Randomized Controlled Trial. J Hepatol 2011;54:1161-7
  • Kumar M, Sakhuja P, Kumar A, Manglik N, Choudhury A, Hissar S, Rastogi A, Sarin SK. Histological sub-classification of cirrhosis based on histological-hemodynamic correlation. Aliment Pharmacol Ther 2008;27:771-9
  • Rastogi A, Bihari C, Maiwall R, Ahuja A, Sharma MK, Kumar A, Sarin SK. Hepatic stellate cells are involved in the pathogenesis of acute-on-chronic liver failure (ACLF). Virchows Arch 2012;461:393-8
  • Sharma P, Singh S, Sharma BC, Kumar M, Garg H, Kumar A, Sarin SK. Propofol sedation during endoscopy in patients with cirrhosis, and utility of psychometric tests and critical flicker frequency in assessment of recovery from sedation. Endoscopy 2011;43:400-5
  • Tyagi P, Sharma P, Sharma BC, Puri AS, Kumar A, Sarin SK. Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo. Eur J Gastroenterol Hepatol 2011;23:210-7
  • Puri M, Patra S, Singh P, Malhotra N, Trivedi SS, Sharma S, Kumar A, Sarin SK. Factors influencing occurrence of postpartum haemorrhage in pregnant women with hepatitis E infection and deranged coagulation profile. Obstetric Medicine 2011;4:108–112
  • Member of the European Association for the Study of the Liver (EASL)
  • Member of the Indian Association for the Study of the Liver (INASL)
  • Member of Indian Society of Gastroenterology (ISG)
  • Member of Association of Physicians of India (API)
  • Member of Indian Medical Association (IMA)
-->